Cipla Patalganga facility gets 6 USFDA observations
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
New leadership team announced at NATHEALTH Annual General Meeting 2024
Subscribe To Our Newsletter & Stay Updated